Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 5
1953 1
1955 2
1956 2
1957 1
1960 4
1961 13
1962 14
1963 20
1964 15
1965 9
1966 17
1967 21
1968 22
1969 12
1970 19
1971 24
1972 18
1973 15
1974 19
1975 17
1976 27
1977 26
1978 55
1979 54
1980 45
1981 58
1982 69
1983 83
1984 81
1985 98
1986 115
1987 104
1988 114
1989 109
1990 111
1991 108
1992 127
1993 137
1994 141
1995 169
1996 176
1997 161
1998 177
1999 218
2000 224
2001 225
2002 240
2003 283
2004 293
2005 271
2006 298
2007 292
2008 338
2009 327
2010 316
2011 386
2012 385
2013 398
2014 419
2015 459
2016 476
2017 527
2018 459
2019 548
2020 659
2021 736
2022 319
Text availability
Article attribute
Article type
Publication date

Search Results

10,713 results
Results by year
Filters applied: . Clear all
Page 1
A neutrophil activation signature predicts critical illness and mortality in COVID-19.
Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. Meizlish ML, et al. Among authors: yamamoto y. Blood Adv. 2021 Mar 9;5(5):1164-1177. doi: 10.1182/bloodadvances.2020003568. Blood Adv. 2021. PMID: 33635335 Free PMC article.
Multicellular modeling of ciliopathy by combining iPS cells and microfluidic airway-on-a-chip technology.
Sone N, Konishi S, Igura K, Tamai K, Ikeo S, Korogi Y, Kanagaki S, Namba T, Yamamoto Y, Xu Y, Takeuchi K, Adachi Y, Chen-Yoshikawa TF, Date H, Hagiwara M, Tsukita S, Hirai T, Torisawa YS, Gotoh S. Sone N, et al. Among authors: yamamoto y. Sci Transl Med. 2021 Jul 7;13(601):eabb1298. doi: 10.1126/scitranslmed.abb1298. Sci Transl Med. 2021. PMID: 34233948
Reply.
Yamazaki H, Wang J, Yamamoto Y. Yamazaki H, et al. Among authors: yamamoto y. Clin Gastroenterol Hepatol. 2022 Feb;20(2):472. doi: 10.1016/j.cgh.2021.03.051. Epub 2021 Apr 2. Clin Gastroenterol Hepatol. 2022. PMID: 33819665 No abstract available.
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD.
Roboon J, Hattori T, Ishii H, Takarada-Iemata M, Nguyen DT, Heer CD, O'Meally D, Brenner C, Yamamoto Y, Okamoto H, Higashida H, Hori O. Roboon J, et al. Among authors: yamamoto y. J Neurochem. 2021 Jul;158(2):311-327. doi: 10.1111/jnc.15367. Epub 2021 May 9. J Neurochem. 2021. PMID: 33871064
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Sho T, Suda G, Ogawa K, Kimura M, Kubo A, Tokuchi Y, Kitagataya T, Maehara O, Ohnishi S, Shigesawa T, Nakamura A, Yamada R, Ohara M, Kawagishi N, Natsuizaka M, Nakai M, Morikawa K, Furuya K, Baba M, Yamamoto Y, Suzuki K, Izumi T, Meguro T, Terashita K, Ito J, Miyagishima T, Sakamoto N. Sho T, et al. Among authors: yamamoto y. Hepatol Res. 2021 Sep;51(9):979-989. doi: 10.1111/hepr.13693. Epub 2021 Jul 20. Hepatol Res. 2021. PMID: 34245216
The effects of androgens on metabolic functions in females.
Iwasa T, Yamamoto Y, Shinya A, Minato S, Yanagihara R, Kamada S, Imaizumi J, Kagawa T, Shirakawa A, Noguchi H, Nakagawa T, Taniguchi M, Kadota Y, Kawakita T, Yoshida K, Kato T, Yasui T, Irahara M. Iwasa T, et al. Among authors: yamamoto y. J Med Invest. 2021;68(3.4):228-231. doi: 10.2152/jmi.68.228. J Med Invest. 2021. PMID: 34759135 Free article.
The In Vivo Selection Method in Breast Cancer Metastasis.
Nakayama J, Han Y, Kuroiwa Y, Azuma K, Yamamoto Y, Semba K. Nakayama J, et al. Among authors: yamamoto y. Int J Mol Sci. 2021 Feb 14;22(4):1886. doi: 10.3390/ijms22041886. Int J Mol Sci. 2021. PMID: 33672831 Free PMC article. Review.
10,713 results
You have reached the last available page of results. Please see the User Guide for more information.